Senior Director, BD Search - Boston, MA, United States - Takeda
Description
Senior Director, BD Search & Evaluation Lead, Global OncologyAt Takeda Oncology, we aspire to cure cancer, with inspiration from patients and innovation from everywhere.
As a member of our team, you would bring your unique perspective to help us achieve our aspiration and help us demonstrate our commitment to patients on a daily basis.
We ensure a tight connection from research to development to commercialization to rapidly meet the needs of the cancer community, optimizing our ability to bring transformative medicines to patients.
Our demonstrated leadership in the treatment of hematologic cancers and solid tumors, combined with cutting-edge science through multiple platforms, partnerships and therapeutic approaches, enable us to bring novel medicines to patients worldwide.
At Takeda, you will have access to the resources of a company with over 200 years of heritage, a diverse and robust pipeline, a values-driven culture and career development opportunities.
By clicking the "Apply" button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda's Privacy Notice and Terms of Use .
I further attest that all information I submit in my employment application is true to the best of my knowledge.
As a member of Takeda Oncology, your work will contribute to our bold, inspiring vision: As part of the Global Oncology Products and Pipeline Strategy team, you will report to Vice President, Global Oncology Products & Pipeline Strategy and work with Global Business Development (GBD), Center for External Innovation (CEI), New Products Planning (NPP), Oncology Therapeutic Area Unit (OTAU), and Oncology Drug Discovery Unit (ODDU) to evolve and drive Takeda Oncology BD goals and strategy.
In collaboration with Global and Local Business Development, Center for External Innovation (CEI), New Products Planning (NPP), Oncology Therapeutic Area Unit (OTAU), Oncology Drug Discovery Unit (ODDU) and Cell Therapy Translational Engine (CTTE) :Refine and align the Takeda Oncology BD goals and strategy
Identify, monitor and review near-term (within 3 years of regulatory approval) oncology partnering opportunities
Lead / co-lead scientific / technical review of external oncology partnering opportunities
Co-represent Takeda Oncology at major oncology related meetings such as: AACR, ASCO, ESMO, ASH among others
Co-represent Takeda Oncology at major Bio-partnering meeting such as: JPM Conference, BIO, BIO-Europe among others
In collaboration with Global (and Local) Business Development (GBD), Center for External Innovation (CEI) and New Products Planning (NPP), identify, monitor and review near-term (within 3 years of regulatory approval) oncology partnering opportunities that meet the Takeda Oncology BD strategy
In collaboration with Global Product / Project Teams and Global Medical Affairs (GMA), assist in the development of Life Cycle Management (LCM) plans that:
Expand / investigate the utility of Takeda Oncology agents within their primary oncology indication
Expand / investigate the possible utility of Takeda Oncology agents to other oncology indications
Expand / investigate the possible utility of Takeda Oncology agents to non-oncology indications
Explore / maximum cost effectiveness of external medical / clinical collaborations with NCI, Oncology Cooperative Groups as well as major Oncology Cancer Centers.
In collaboration with CEI, ODDU, CTTE and Takeda Ventures/ TVI participate in the identification and review of early stage (pre-clinical proof of concept) oncology opportunities for either partnering and/or investment.
In collaboration with Global Regulatory Affairs (GRA), monitor and communication with Takeda Oncology current and emerging regulatory initiatives in the following areas:Novel endpoints for regulatory approval
Novel statistical designs to support regulatory approval
Novel regulatory review guidelines for approval of cancer drugs and /or cancer biomarkers
In collaboration with OBU Scientific & Competitive Analysis (SCA) and R+D Competitive Intelligence (CI) and Data Sciences Institute (DSI) teams:
Monitor the current as well as emerging Oncology Competitive Landscape and Medical Landscape in key oncology areas of interest
In collaboration with Onconnect Committee, NPP and DAS Teams, work to develop series of Oncology Seminars/ KOLs interactions to educate Takeda on current and future emerging medical landscapes in key oncology disease areas as well as emerging treatment / technologies for cancer.
In collaboration with program management, to ensure that projects are properly and accurately trackedCo-lead governance activities including PRC and BSC as well as draft appropriate sections to governance documents.
At least 10 years experience in Business Development and Licensing within pharmaceutical or biotech sector, with focus on oncology, hematology or immuno-oncology.
A track record of success in sourcing/driving business development opportunities for the commercial organizationA well-established commercial/academic network is strongly preferred along with a progressive knowledge of creative alliance structures, industry trends, and competitive issues related to pharmaceutical business development.
At Takeda, we are transforming patient care through the development of novel specialty pharmaceuticals and best in class patient support programs.
Certified as a Global Top Employer, Takeda offers stimulating careers, encourages innovation, and strives for excellence in everything we do.
We foster an inclusive, collaborative workplace, in which our teams are united by an unwavering commitment to deliver Better Health and a Brighter Future to people around the world.
This position is currently classified as "hybrid" in accordance with Takeda's Hybrid and Remote Work policy.#00
By clicking the "Apply" button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda's Privacy Notice and Terms of Use .
I further attest that all information I submit in my employment application is true to the best of my knowledge.
As a member of Takeda Oncology, your work will contribute to our bold, inspiring vision: As part of the Global Oncology Products and Pipeline Strategy team, you will report to Vice President, Global Oncology Products & Pipeline Strategy and work with Global Business Development (GBD), Center for External Innovation (CEI), New Products Planning (NPP), Oncology Therapeutic Area Unit (OTAU), and Oncology Drug Discovery Unit (ODDU) to evolve and drive Takeda Oncology BD goals and strategy.
In collaboration with Global and Local Business Development, Center for External Innovation (CEI), New Products Planning (NPP), Oncology Therapeutic Area Unit (OTAU), Oncology Drug Discovery Unit (ODDU) and Cell Therapy Translational Engine (CTTE) :Refine and align the Takeda Oncology BD goals and strategy
Identify, monitor and review near-term (within 3 years of regulatory approval) oncology partnering opportunities
Lead / co-lead scientific / technical review of external oncology partnering opportunities
Co-represent Takeda Oncology at major oncology related meetings such as: AACR, ASCO, ESMO, ASH among others
Co-represent Takeda Oncology at major Bio-partnering meeting such as: JPM Conference, BIO, BIO-Europe among others
In collaboration with Global (and Local) Business Development (GBD), Center for External Innovation (CEI) and New Products Planning (NPP), identify, monitor and review near-term (within 3 years of regulatory approval) oncology partnering opportunities that meet the Takeda Oncology BD strategy
In collaboration with Global Product / Project Teams and Global Medical Affairs (GMA), assist in the development of Life Cycle Management (LCM) plans that:
Expand / investigate the utility of Takeda Oncology agents within their primary oncology indication
Expand / investigate the possible utility of Takeda Oncology agents to other oncology indications
Expand / investigate the possible utility of Takeda Oncology agents to non-oncology indications
Explore / maximum cost effectiveness of external medical / clinical collaborations with NCI, Oncology Cooperative Groups as well as major Oncology Cancer Centers.
In collaboration with CEI, ODDU, CTTE and Takeda Ventures/ TVI participate in the identification and review of early stage (pre-clinical proof of concept) oncology opportunities for either partnering and/or investment.
In collaboration with Global Regulatory Affairs (GRA), monitor and communication with Takeda Oncology current and emerging regulatory initiatives in the following areas:Novel endpoints for regulatory approval
Novel statistical designs to support regulatory approval
Novel regulatory review guidelines for approval of cancer drugs and /or cancer biomarkers
In collaboration with OBU Scientific & Competitive Analysis (SCA) and R+D Competitive Intelligence (CI) and Data Sciences Institute (DSI) teams:
Monitor the current as well as emerging Oncology Competitive Landscape and Medical Landscape in key oncology areas of interest
In collaboration with Onconnect Committee, NPP and DAS Teams, work to develop series of Oncology Seminars/ KOLs interactions to educate Takeda on current and future emerging medical landscapes in key oncology disease areas as well as emerging treatment / technologies for cancer.
In collaboration with program management, to ensure that projects are properly and accurately trackedCo-lead governance activities including PRC and BSC as well as draft appropriate sections to governance documents.
MBA/PhD/MD degrees preferred.
At least 10 years experience in Business Development and Licensing within pharmaceutical or biotech sector, with focus on oncology, hematology or immuno-oncology.
A track record of success in sourcing/driving business development opportunities for the commercial organizationA well-established commercial/academic network is strongly preferred along with a progressive knowledge of creative alliance structures, industry trends, and competitive issues related to pharmaceutical business development.
At Takeda, we are transforming patient care through the development of novel specialty pharmaceuticals and best in class patient support programs.
Certified as a Global Top Employer, Takeda offers stimulating careers, encourages innovation, and strives for excellence in everything we do.
We foster an inclusive, collaborative workplace, in which our teams are united by an unwavering commitment to deliver Better Health and a Brighter Future to people around the world.
This position is currently classified as "hybrid" in accordance with Takeda's Hybrid and Remote Work policy.#The actual base salary offered will be in accordance with state or local minimum wage requirements for the job location.
S.
based employees may be eligible to participate in medical, dental, vision insurance, a 401(k) plan and company match, short-term and long-term disability coverage, basic life insurance, a tuition reimbursement program, paid volunteer time off, company holidays, and well-being benefits, among others.
Takeda is proud in its commitment to creating a diverse workforce and providing equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, gender expression, parental status, national origin, age, disability, citizenship status, genetic information or characteristics, marital status, status as a Vietnam era veteran, special disabled veteran, or other protected veteran in accordance with applicable federal, state and local laws, and any other characteristic protected by law.
Full time It's not about the headlines at Takeda. InclusionInclusion
Innovation
Bold initiatives, continuous improvement, and creativity are at the heart of how we bring scientific breakthroughs from the lab to patients.
Our people-first mission extends beyond patients to include their families, communities, and our own Takeda family. Through trust and respect, you will have genuine support from leaders, managers, and colleagues to do your best work.Our belief in putting people first extends beyond our patients — it includes their families and communities, as well as our Takeda colleagues and their families.
We are committed to embracing our differences, valuing different perspectives, and fostering a culture of respect, inclusiveness and empowerment.
Our embedded Diversity, Equity & Inclusion (DE&I) strategy enables us to attract and retain exceptional talent, drives innovation, and helps address systemic inequalities in our communities.
Responsibly translate science into highly innovative medicines and accelerate access to improve lives worldwide.Data & Digital
Transform Takeda into the most trusted, data-driven, outcomes-based biopharmaceutical company.
Plus, get the latest in company news and other important resources by signing up for our talent community.
#